Parkinson's Disease Clinical Trial
Official title:
Instrumental or Physical-exercise Rehabilitation of Balance Improve Both Balance and Gait in Parkinson's Disease.
We hypothesized that rehabilitation specifically addressing balance in Parkinson ́s disease patients might improve not only balance, but locomotion as well. Two balance training protocols (standing on a moving platform, and traditional balance exercises) were compared by assigning patients to two groups: moving platform (n=15) and balance exercises (n=17). Platform moved periodically in antero-posterior, latero-lateral and oblique direction, with and without vision in different trials. Balance exercises were based on Otago Exercise Program. Both platform and exercises sessions were administered from easy to difficult. Outcome measures were: a) balancing behaviour, assessed both by index of stability (IS) on platform and by Mini-BESTest, b) gait, assessed both by baropodometry and by Timed Up and Go (TUG) test. Falls Efficacy Scale-International (FES-I) and Parkinson's Disease Questionnaire (PDQ-8) were administered. Both groups exhibited better balance control, as assessed both by IS and by Mini-BESTest. Gait speed at both baropodometry and TUG also improved in both groups. Scores of FES-I and PDQ-8 showed a marginal improvement. A four-week treatment featuring no gait training, but focussed on challenging balance tasks produces considerable gait enhancement in mildly to moderately affected patients. Walking problems in PD depend on postural instability and are successfully relieved by appropriate balance rehabilitation.
The importance for training balance in connection with rehabilitation aimed at improving gait
is easily stressed by considering the complex motor behaviour underpinning more challenging
conditions than linear walking, as walking-and-turning, where the turn-related changes in
feet, trunk and head movements are integral part of he kinematics of the steering body
(Courtine and M. Schieppati, 2003; Crenna et al, 2007). It is no wonder that freezing of gait
and increased risk of falling (Schlenstedt et al., 2016) is associated with abnormal
bilateral coordination and turning. Hence, the present investigation somehow diverges from
the theory of the task-specific training (Bayona et al., 2005), but considers instead the
relevance for locomotion enhancement of training balance control, by hypothesising that
specific balance rehabilitation might be sufficient for gait improvement. Here, we trained PD
patients with two different treatments, both specifically addressing balance. A platform onto
which subjects stood moved in antero-posterior, latero-lateral and diagonal direction in the
horizontal plane. A simpler moving-platform protocol had been previously exploited for
testing and enhancing balance capacities in patients with PD and with vestibular deficit
(Nardone et al., 2010; De Nunzio 2007). This platform protocol challenges both the
anticipatory and the reactive capacities to the ongoing postural perturbations, thereby
training dynamic balance control, aiming at the balance problems encountered during every day
activity.
The outcome of the platform treatment was compared to that obtained in another group of
matched patients with PD by standardized and validated exercises aimed at training balance
and dynamic balance (Renfro et al., 2016). Of note, these exercises contained no dynamic
component (i.e. gait-related exercises) of balance training, contrary to Conradsson et al.
2017. Both treatments (platform and exercises) were tailored to the patient individual
capacities, and their difficulty gradually increased all along the duration of the treatment
(Conradsson et al., 2017). In this context, we estimated any improvement in balance control
by indexes of dynamic stability during a balance perturbation test on the mobile platform and
by clinical scores related to dynamic balance control. Gait improvement was both evaluated
instrumentally and assessed by a functional clinical test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |